Antibody response and therapy in COVID-19 patients: what can be learned for vaccine development?

The newly emerged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected millions of people and caused tremendous morbidity and mortality worldwide. Effective treatment for coronavirus disease 2019 (COVID-19) due to SARS-CoV-2 infection is lacking, and different therapeutic strate...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Ligong, Zhang, Hui, Zhan, Meixiao, Jiang, Jun, Yin, Hua, Dauphars, Danielle J., Li, Shi-You, Li, Yong, He, You-Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Science China Press 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756132/
https://www.ncbi.nlm.nih.gov/pubmed/33355886
http://dx.doi.org/10.1007/s11427-020-1859-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756132/
https://www.ncbi.nlm.nih.gov/pubmed/33355886
http://dx.doi.org/10.1007/s11427-020-1859-y

Ejemplares similares